Member of the board since 2013, Chairmen of the board since April 2021
Jan Zetterberg has 39 years of legal experience in pharmaceutical industry, mostly AstraZeneca, serving as Legal Counsel, Senior Counsel, Vice President, Strategy, Intellectual Property and Assistant General Counsel. He has provided global legal support in all areas of business including corporate functions, R&D, Operations, and Business Development. Jan Zetterberg is elected Chairman of the Board of Oxcia AB and ExThera AB. He is also board member of Elicera Therapeutics AB and Thomas Helledays Foundation for medical research. Jan Zetterberg obtained his L.L.B in Law and economics from Uppsala University in 1975.
Holdings : 0 A-shares, 220 000 B-shares and 215 000 warrants
Dependent in relation to the Company and its management and the Company’s major shareholders.